Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

GenVec, Inc. (GNVC)

-NasdaqCM
2.66 Up 0.16(6.40%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
GenVec, Inc.
910 Clopper Road
Suite 220N
Gaithersburg, MD 20878
United States - Map
Phone: 240-632-0740
Fax: 240-632-0735
Website: http://www.genvec.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:11

Business Summary 

GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines. The company develops its product candidates through collaborations with various companies and organizations, including Novartis AG, Merial Limited, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of various human and animal health concerns. Its development programs address various therapeutic areas, such as hearing loss and balance disorders; and vaccines against infectious diseases, including respiratory syncytial virus, herpes simplex virus, dengue fever, and malaria. The company is also involved in developing vaccines against foot-and-mouth disease in the area of animal health. GenVec, Inc. was founded in 1992 and is based in Gaithersburg, Maryland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on GenVec, Inc.

Key Executives 
 PayExercised
Mr. Douglas J. Swirsky CPA, CFA, 44
Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corp. Sec. and Director
322.00K0.00
Dr. Douglas E. Brough Ph.D., 59
Chief Scientific Officer
317.00K0.00
Dr. Bryan T. Butman Ph.D., 61
Sr. VP of Devel.
284.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders